Broad neural network modulation

Broad neural network modulation refers to the systemic alteration of activity and connectivity across large-scale brain circuits rather than the targeting of a single localized receptor or protein (International Neuromodulation Society, 2024). This approach is central to the therapeutic effects of rapid-acting antidepressants and psychedelics, which reorganize functional connectivity and promote synaptic plasticity to treat complex neuropsychiatric conditions (Carhart-Harris & Friston, 2019, Pharmacological Reviews). Unlike traditional pharmacology that focuses on discrete molecular targets, broad modulation involves the coordinated response of multiple neurotransmitter systems, such as glutamate and serotonin, to shift the brain's global state (Duman et al., 2016, Nature Medicine). While this systems-level effect is highly effective for treatment-resistant depression and PTSD, it presents challenges in drug development due to the lack of a single molecular endpoint for optimization (Vollenweider & Kometer, 2010, Nature Reviews Neuroscience). Consequently, this term describes a pharmacological outcome or therapeutic strategy rather than a canonical biological target like an enzyme or ion channel. Monitoring these effects typically requires advanced neuroimaging techniques like fMRI or EEG to assess changes in network dynamics and connectivity (Brodbeck et al., 2012, Lancet Neurology).

Other names

NeuromodulationSystems-level neural modulationNetwork-level brain modulationGlobal brain state modulation

Alteration of global brain connectivity, excitatory/inhibitory balance, and induction of rapid synaptogenesis across multiple brain regions.